VETOQUINOL Corporate brochure 2010 (year 2009)

2009 revenues by Territory ■ 61 % Western Europe ■ 8 % Eastern Europe ■ 23 % North America ■ 8 % Rest of the World 2009 revenues by Therapeutic Class ■ 44 % Anti-infectives ■ 13 % Pain-inflammation ■ 4 % Cardiology-Nephrology ■ 39 % Other 2009 revenues by Species ■ 50 % Companion Animals ■ 32 % Cattle ■ 12 % Pigs ■ 6 % Other ACTIVITY REPORT 2009 29